对功能性粉样蛋白形成的表面影响
Alexander J Dear1,2, Georg Meisl1, Christopher G Taylor1
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
Nanoscale
|August 13, 2024
概括
表面相互作用显著影响 Pseudomonas FapC 蛋白质的功能性粉样蛋白的形成. 这项研究表明,表面催化粉样蛋白核化,影响生物膜形成和抗菌素耐药性.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
背景情况:
- 来自Pseudomonas FapC蛋白的功能性粉样蛋白对细菌生物膜至关重要.
- 这些生物膜有助于慢性感染和抗菌素耐药性.
研究的目的:
- 调查表面在FapC功能性粉样蛋白形成中的作用.
- 了解粉样蛋白核和催化机制.
主要方法:
- 使用了动力实验和机械模型.
- 研究了反应容器表面和微滴对核形成的影响.
- 具有量身定制的表面特性的纳米粒子被用于调整催化剂.
主要成果:
- 粉样纤维细胞核形成主要是异质的,由反应器壁催化.
- 移除接口减缓了初级核形成,揭示了由现有的纤维素催化的二次核形成步骤.
- 核化速率由FapC与催化位点和表面积的结合强度控制,而不是电荷或水友性.
结论:
- 表面化学和面积是控制FapC粉样蛋白核化的关键因素.
- 蛋白质聚合和纤维细胞核形成基本上是异质的过程.
- 实验设计,包括反应容器表面特性,对于研究粉样蛋白形成至关重要.
更多相关视频
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
9.3K
06:17A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
11.8K
相关概念视频
Amyloid Fibrils
9.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.4K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
